Inborn Errors of Intermediary Metabolism in Critically Ill Mexican Newborns

AUTOR(ES)

Isabel, Ibarra-Gonález

FONTE

J. inborn errors metab. screen.

DATA DE PUBLICAÇÃO

15/07/2019

RESUMO

Abstract Inborn errors of intermediary metabolism (IEiM) are complex diseases with high clinical heterogeneity, and some patients who have severe enzyme deficiencies or are subjected to stress (catabolism/infections) actually decompensate in the neonatal period. In this study, we performed metabolic tests on 2025 newborns in Mexico admitted to 35 neonatal intensive care units or emergency wards (NICUs/EWs) over a 6-year period, in whom a metabolic disorder was clinically suspected. Of these 2025 newborns with sickness, 11 had IEiM, revealing a prevalence of 1:184. Clinical characteristics and outcomes of the newborns with confirmed IEiM are shown. Of these 11 patients, 4 had isolated methylmalonic acidemia, 3 had maple syrup urine disease, 2 had urea cycle disorders, 1 had 3-hydroxy-3-methylglutaric acidemia, and 1 had isovaleric acidemia. During the first week of life (average 3 days), all of these newborns presented with impaired alertness, hypotonia, feeding difficulties, and vomiting along with metabolic acidosis and hyperammonemia. Of the 11 newborns with IEiM, 7 died, leading to a mortality rate of 64%. In conclusion, the differential diagnosis of newborns admitted to the NICU/EW must include IEiM, requiring systematic screening of this population.

Documentos Relacionados

• Incidence of Inborn Errors of Metabolism by Expanded Newborn Screening in a Mexican Hospital
• Inborn Errors of Metabolism
• Recent Advances in Inborn Errors of Metabolism
• Advances in the Treatment of Inborn Errors of Metabolism
• Screening for inborn errors of metabolism among newborns with metabolic disturbance and/or neurological manifestations without determined cause